Ischemic preconditioning inhibits over-expression of arginyl-tRNA synthetase gene Rars in ischemia-injured neurons

Abstract

The expression changes of Rars gene in ischemia-injured neurons were investigated by detecting its translational product arginyl-tRNA synthetase (ArgRS), and the inhibitory effects of ischemic preconditioning (IPC) on Rars gene were explored. Both IPC model and prolonged ischemia (PI) model were established by using the classic oxygen glucose deprivation (OGD) method. The primary cultured neurons were assigned into the following groups: the experimental group (IPC+PI group), undergoing PI after a short period of IPC; the conditional control group (PI control group), subjected to PI without IPC; blank control group, the normally cultured neurons. The Rars transcriptional activities and ArgRS expression levels were measured at different time points after re-oxygenation (3 h/6 h/12 h/24 h). Data were collected and statistically analyzed. Compared to the blank control group, the Rars activities and ArgRS levels were significantly increased in PI control group, peaking at the time point of 6 h after re-oxygenation. Rars activities and ArgRS levels were significantly lower in the experimental group than in the PI control group at different time points after re-oxygenation. PI insult can induce an escalating activity of Rars and lead to ArgRS over-expression in primary cultured neurons. IPC can inhibit the increased Rars activity and down-regulate ArgRS expression of ischemia-insulted neurons. This mechanism may confer ischemic tolerance on neurons.

Keywords

ischemic preconditioning / arginyl-tRNA synthetase / Rars / oxygen glucose deprivation

References

[1] LingJ, ReynoldsN, IbbaM. Aminoacyl-tRNA synthesis and translational quality control. Annu Rev Microbiol, 2009, 63: 61-78 PMID: 19379069

[2] AndersonLL, MaoX, ScottBA, et al. . Survival from hypoxia in C. elegans by inactivation of aminoacyl-tRNA synthetases. Science, 2009, 323(5914): 630-633 PMID: 19179530

[3] FuR, FanYZ, FanYC, et al. . Expression of arginyl-tRNA synthetase in rats with focal cerebral ischemia. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(2): 172-175 PMID: 24710927

[4] DirnaglU, BeckerK, MeiselA. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol, 2009, 8(4): 398-412 PMID: 19296922 PMCID: 2668955

[5] LiuXQ, ShengR, QinZH. The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin, 2009, 30(8): 1071-1080 PMID: 19617892 PMCID: 4006675

[6] ThompsonJW, DaveKR, YoungJI, et al. . Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance. Neurotherapeutics, 2013, 10(4): 789-797 PMID: 23868468 PMCID: 3805868

[7] SisalliMJ, AnnunziatoL, ScorzielloA. Novel cellular mechanisms for neuroprotection in ischemic preconditioning: A view from inside organelles. Front Neurol, 2015, 6: 115 PMID: 26074868 PMCID: 4443717

[8] KamphuisW, DijkF, BergenAA. Ischemic preconditioning alters the pattern of gene expression changes in response to full retinal ischemia. Mol Vis, 2007, 13: 1892-1901 PMID: 17960128

[9] NarayananSV, DaveKR, Perez-PinzonMA. Ischemic preconditioning and clinical scenarios. Curr Opin Neurol, 2013, 26(1): 1-7 PMID: 23197083 PMCID: 3752400

[10] RossAP, ChristianSL, ZhaoHW, et al. . Persistent tolerance to oxygen and nutrient deprivation and N-methyl-D-aspartate in cultured hippocampal slices from hibernating Arctic ground squirrel. J Cereb Blood Flow Metab, 2006, 26(9): 1148-1156 PMID: 16395285

[11] NathanielTI. Brain-regulated metabolic suppression during hibernation: a neuroprotective mechanism for perinatal hypoxia-ischemia. Int J Stroke, 2008, 3(2): 98-104 PMID: 18706003